Joe Barton actually said...
Mr. Davis just said, CMS has announced that they're going to reverse their earlier policy and assign a separate HCPCS code for each biosimilar rather than have a single payment rate.
Context
Barton discusses CMS's reversal on biosimilar payment policy.
12/12/2017